SCHOTT Pharma AG & Co. KGaA (ETR:1SXP)
Germany · Delayed Price · Currency is EUR 21.85
-1.50 (-6.42%)
At close: Nov 5, 2026
ETR:1SXP Financials Overview
Financials in millions EUR. Fiscal year is October - September.
Millions EUR. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Revenue Revenue Growth | 1,017 | 986.21 | 957.09 | 898.6 | 821.14 | 648.67 |
Revenue Growth | 4.15% | 3.04% | 6.51% | 9.43% | 26.59% | 11.03% |
Gross Profit Gross Profit Growth | 316.91 | 332.46 | 322.61 | 316.49 | 296.64 | 226.17 |
Operating Income Operating Income Growth | 167.23 | 185.74 | 188.84 | 171.21 | 168.01 | 114.5 |
Net Income Net Income Growth | 136.22 | 146.45 | 149.69 | 151.84 | 125.38 | 100.75 |
Earnings Per Share EPS Growth | 0.90 | 0.97 | 0.99 | 1.01 | 0.83 | 0.67 |
EPS Growth | -7.25% | -2.02% | -1.80% | 21.46% | 24.08% | 31.17% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Drug Containment Solutions (DCS) Drug Containment Solutions (DCS) Growth | 579.51 | 548.01 | 518.72 | 558 | 598.92 | 492.13 |
Drug Delivery Systems (DDS) Drug Delivery Systems (DDS) Growth | 438.06 | 438.76 | 438.74 | 343.64 | 222.86 | 157.68 |
Consolidation/Reconciliation Consolidation/Reconciliation Growth | -0.76 | -0.56 | -0.37 | -3.03 | -0.64 | -1.14 |
Total Total Growth | 1,017 | 986.21 | 957.09 | 898.6 | 821.14 | 648.67 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Cash & Investments Cash & Investments Growth | 24.88 | 25.67 | 26.43 | 25.89 | 30.28 | 27.86 |
Total Debt Total Debt Growth | 308.26 | 302.97 | 286.34 | 209.81 | 195.38 | 100.58 |
Net Cash (Debt) Net Cash Growth | -283.38 | -277.3 | -259.91 | -183.92 | -165.09 | -72.72 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -1.88 | -1.84 | -1.73 | -1.22 | -1.10 | -0.48 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 192.92 | 179.92 | 224.77 | 181.65 | 182.12 | 132.21 |
Capital Expenditures CapEx Growth | -137.74 | -144.32 | -145.08 | -175.47 | -152.01 | -98.07 |
Free Cash Flow Free Cash Flow Growth | 55.18 | 35.6 | 79.69 | 6.19 | 30.11 | 34.14 |
Free Cash Flow Growth | 11.11% | -55.33% | 1188.50% | -79.46% | -11.80% | 77.60% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Gross Margin | 31.17% | 33.71% | 33.71% | 35.22% | 36.13% | 34.87% |
Operating Margin | 16.45% | 18.83% | 19.73% | 19.05% | 20.46% | 17.65% |
Pretax Margin | 17.21% | 19.04% | 19.22% | 20.68% | 19.28% | 19.01% |
Profit Margin | 13.40% | 14.85% | 15.64% | 16.90% | 15.27% | 15.53% |
FCF Margin | 5.43% | 3.61% | 8.33% | 0.69% | 3.67% | 5.26% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 5, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.180 | 0.180 | 0.160 | 0.150 | 0.125 |
Dividend Per Share Growth | 12.50% | 12.50% | 6.67% | 20.00% | - |
Dividend Yield | 0.82% | 0.85% | 0.52% | 0.47% | - |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 5, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
PE Ratio | 24.28 | 21.70 | 30.85 | 31.38 | - | - |
Forward PE | 19.70 | 19.36 | 30.23 | - | - | - |
P/FCF Ratio | 63.73 | 89.28 | 57.95 | 770.48 | - | - |
PS Ratio | 3.46 | 3.22 | 4.83 | 5.30 | - | - |